Johnson & Johnson (JNJ) stock
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)
Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%
Johnson & Johnson EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Johnson & Johnson's EV/EBITDA was 26.6× on Nov 11, 2026, against 13.3× a year earlier. Over the last 5 years it ranged from 11.1× to 26.6×, with a median of 17.0×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 26.6× | +13.3 |
| 2025 | Dec 31, 2025 | 13.3× | −1.0 |
| 2024 | Dec 31, 2024 | 14.3× | −4.4 |
| 2023 | Dec 29, 2023 | 18.6× | −0.9 |
| 2022 | Dec 30, 2022 | 19.6× | +2.7 |
| 2021 | Dec 31, 2021 | 16.9× | +0.7 |
| 2020 | Dec 31, 2020 | 16.2× | −0.9 |
| 2019 | Dec 31, 2019 | 17.1× | +2.8 |
| 2018 | Dec 31, 2018 | 14.3× | −1.8 |
| 2017 | Dec 29, 2017 | 16.1× | +3.0 |
| 2016 | Dec 30, 2016 | 13.0× | +0.9 |
| 2015 | Dec 31, 2015 | 12.2× | +0.4 |
| 2014 | Dec 31, 2014 | 11.8× | −0.8 |
| 2013 | Dec 31, 2013 | 12.6× | +0.2 |
| 2012 | Dec 31, 2012 | 12.4× | +3.4 |
| 2011 | Dec 30, 2011 | 9.0× | +0.7 |
| 2010 | Dec 31, 2010 | 8.3× | −0.7 |
| 2009 | Dec 31, 2009 | 9.0× | – |
See a number that looks wrong?